Highland Capital Management Lowers stake in CVS Health Corp (CVS)

CVS Health Corp (CVS) : Highland Capital Management reduced its stake in CVS Health Corp by 12.28% during the most recent quarter end. The investment management company now holds a total of 186,969 shares of CVS Health Corp which is valued at $19,115,711 after selling 26,185 shares in CVS Health Corp , the firm said in a disclosure report filed with the SEC on Apr 15, 2016.CVS Health Corp makes up approximately 1.62% of Highland Capital Management’s portfolio.

CVS Health Corp closed down -1.29 points or -1.26% at $101.22 with 40,18,355 shares getting traded on Wednesday. Post opening the session at $102.51, the shares hit an intraday low of $101.03 and an intraday high of $102.87 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

Other Hedge Funds, Including , Bridge Creek Capital Management boosted its stake in CVS in the latest quarter, The investment management firm added 810 additional shares and now holds a total of 39,359 shares of CVS Health Corp which is valued at $4,024,064. CVS Health Corp makes up approx 2.32% of Bridge Creek Capital Management’s portfolio.Culbertson A N Co Inc reduced its stake in CVS by selling 50 shares or 0.05% in the most recent quarter. The Hedge Fund company now holds 109,106 shares of CVS which is valued at $11,154,997. CVS Health Corp makes up approx 4.28% of Culbertson A N Co Inc’s portfolio.E&g Advisors Lp boosted its stake in CVS in the latest quarter, The investment management firm added 1,070 additional shares and now holds a total of 11,170 shares of CVS Health Corp which is valued at $1,142,021. CVS Health Corp makes up approx 0.74% of E&g Advisors Lp’s portfolio.Central Trust Co boosted its stake in CVS in the latest quarter, The investment management firm added 2,497 additional shares and now holds a total of 69,559 shares of CVS Health Corp which is valued at $7,111,712. CVS Health Corp makes up approx 0.56% of Central Trust Co’s portfolio.

On the company’s financial health, CVS Health Corp reported $1.53 EPS for the quarter, based on the information available during the earnings call on Feb 9, 2016. Analyst had a consensus estimate of $1.53. The company had revenue of $41145.00 million for the quarter, compared to analysts expectations of $41126.27 million. The company’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.21 EPS.

Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Barclays on Mar 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .Shares were Reiterated by Mizuho on Feb 10, 2016 to “Buy” and Lowered the Price Target to $ 104 from a previous price target of $113 .CVS Health Corp was Initiated by Atlantic Equities to “Overweight” on Feb 3, 2016.

CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.

Leave a Reply

CVS Health Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on CVS Health Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.